Welcome to ECVERY
Escin 98%; Aescin 98%; Horse Chestnut Extract; CAS 6805-41-0; EINECS 229-880-6
... in phyto-medicine in the treatment of chronic venous insufficiency Escin / Aescin 98% Product NameEscin 98% Synonyms:Aescin 98 ... of chronic venous insufficiency and related vascular andcirculatory disorders.Escin (from Horse Chestnut) is used as a cosmetic ... this does not negate its excellent astringent and toning properties.Escin has astringent, vasoconstrictor, anti-inflammatory, as well as ...
Supplier: Changsha Guanxiang Chemicals Trading Co., Ltd. [China Manufacturers]

Escin IIA

Nov 30, 2012
Escin IIA
Botanical Source:Horse chestnut SynonymEscin IIBAescinIIBMolecular FormulaC54H84O23 Molecular Weight1101.23 CAS NumberN/ASpecificationProduct NameEscin IIB(Aescin IIB)Product NumberPTC-61Product BrandSOLARBIOStorage TempRoom temperatureMol. Formula: C54H84O23 Mol. Weight: 1101.23 Botanical Source:Horse chestnut Purity: > 98%,99% by HPLCPackage: 50mg, 100mg, 1g,10g, 100g, 1kg... Escin IIA
Supplier: Beijing Solarbio Science & Technology Co., Ltd. [China Manufacturers]

Aescine

May 04, 2012
Aescine
Aescine Escin; Aescin; Chestnuts extract CAS No: 6805-41-0 EINECS No: ... weight: 1131.2Construction: Appearance: brown powderSpecification: Aescin 20%,98% HPLCFunctions: Escin is a saponin extract from the Horse Chestnut Tree, in ... particular, the seeds. It is also known as Esculin, Escin, and Rosskastanie. Aescin acts as an astringent, vasoconstrictor, and anti ...
Supplier: Lubon Industry Co., Ltd. [China Manufacturers]

Plant extract PE

Mar 06, 2012
Plant extract PE
... %( Fatty acid)GCHorse Chestnut Extract20%,30%,40%,98%( Aescin or Escin)UVRed Clover plant Extract8%,20%,40%( Isoflavones)HPLCCitrus Aurantinum Extract8 ...
Supplier: Dalian Chem Imp. & Exp. Group Co., Ltd. [China Manufacturers]

About Us | Contact Us | Help | Terms & Conditions
Hot Products: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
Copyright Notice @ 2008-2022 ECVERY Limited and/or its subsidiaries and licensors. All rights reserved.